NO743960L - - Google Patents

Info

Publication number
NO743960L
NO743960L NO743960A NO743960A NO743960L NO 743960 L NO743960 L NO 743960L NO 743960 A NO743960 A NO 743960A NO 743960 A NO743960 A NO 743960A NO 743960 L NO743960 L NO 743960L
Authority
NO
Norway
Prior art keywords
hydroxy
acid
oxocyclopent
enheptanoic
parts
Prior art date
Application number
NO743960A
Other languages
Norwegian (no)
Inventor
R Pappo
P W Collins
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US412428A external-priority patent/US3868413A/en
Application filed by Searle & Co filed Critical Searle & Co
Publication of NO743960L publication Critical patent/NO743960L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C07F3/02Magnesium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

3_hydroksy-2-(4-hydroksy-l-alkynyl) -5_oksocyklopent-l-enalkansyrer og derivater derav. 3_hydroxy-2-(4-hydroxy-1-alkynyl)-5_oxocyclopent-1-enalkanoic acids and derivatives thereof.

Foreliggende oppfinnelse vedrører nye cyklopentan-derivater med den generelle formel: The present invention relates to new cyclopentane derivatives with the general formula:

hvor R er hydrogen eller et alkylradikal med 1-7 karbonatomer; where R is hydrogen or an alkyl radical of 1-7 carbon atoms;

R-^ er hydrogen eller et alkanoylradikal med 1-7 karbonatomer; R-^ is hydrogen or an alkanoyl radical of 1-7 carbon atoms;

R2 er hydrogen eller et alkanoylradikal inneholdende 1-7 karbon atomer; R^er hydrogen eller et alkylradikal inneholdende 1-7 karbonatomer; R^ ~er-et—aiky^^tHi^ 1-7 karbonatomer; R 2 is hydrogen or an alkanoyl radical containing 1-7 carbon atoms; R^ is hydrogen or an alkyl radical containing 1-7 carbon atoms; R^ ~er-et—aiky^^tHi^ 1-7 carbon atoms;

m er 6 eller 7; og hvor de bølgeformede linjer indikerer den alternative R og S absolutte stereokjemiske konfigurasjon eller de epimere blanding. m is 6 or 7; and where the wavy lines indicate the alternative R and S absolute stereochemical configuration or the epimeric mixture.

Alkylradikalene i ovenstående formel kan eksemplifiseres ved metyl, etyl, propyl, butyl, heksyl, heptyl og isomerer derav med forgrenet kjede. The alkyl radicals in the above formula can be exemplified by methyl, ethyl, propyl, butyl, hexyl, heptyl and isomers thereof with a branched chain.

Alkanoylradikalene kan eksemplifiseres ved formyl, acetyl, propionyl, butyryl, valeryl, kaproyl, heptanoyl og de tilsvarende isomerer med forgrenet kjede. The alkanoyl radicals can be exemplified by formyl, acetyl, propionyl, butyryl, valeryl, caproyl, heptanoyl and the corresponding isomers with a branched chain.

De nye forbindelser fremstilles ved å kondensere en forbindelse med den generelle formel: hvor R, m og den bølgeformede linje har den ovenfor angitte betydning, alkylgruppen inneholder 1-4 karbonatomer,<p>g R' er hydrogen eller metoksymetyl, med en organometallisk forbindelse med den generelle formel: The new compounds are prepared by condensing a compound of the general formula: where R, m and the wavy line have the meaning given above, the alkyl group contains 1-4 carbon atoms,<p>g R' is hydrogen or methoxymethyl, with an organometallic compound with the general formula:

hvor R^og de bølgeformede linjer har den ovenfor angitte betydning, og R" er hydrogen, tetrahydropyran-2-yl, eller trialkylsilyl, hvor alkylgruppen inneholder 1-4 karbonatomer. Reaksjonen utføres i et inert organisk oppløsningsmiddel, fortrinnsvis en eter slik som where R^ and the wavy lines have the above meaning, and R" is hydrogen, tetrahydropyran-2-yl, or trialkylsilyl, where the alkyl group contains 1-4 carbon atoms. The reaction is carried out in an inert organic solvent, preferably an ether such as

tetrahydrofuran. Selv om reaktantene kan være blandet ved romtemperatur, er det nyttig å oppvarme reaksjonsblandingen til til-bakeløpstemperatur for oppløsningsmidlet for å sikre fullstendig reaksjon..Den sluttlige reaksjonsblanding behandles med syre på vanlig måte for å hydrolysere det organometalliske addukt og fjerne eventuelle beskyttende grupper. tetrahydrofuran. Although the reactants may be mixed at room temperature, it is useful to heat the reaction mixture to the reflux temperature of the solvent to ensure complete reaction. The final reaction mixture is treated with acid in the usual manner to hydrolyze the organometallic adduct and remove any protecting groups.

De benyttede tertiære alkoholer som definert i foregående strukturelle formel hvor R^ er et alkylradikal, fremstilles fortrinnsvis ved omsetning av den passende Grignard-reagens med et 4-metoksymetoksycyklop.entanderivat av den type som er beskrevet i US-patent nr. 3-558.682. 2-metoksy-4-metoksymetoksy-4-oksocyklopent-l-enheptansyre f.eks, kan således omsettes med 4(RS)-tetra-hydropyran-2-yloksy-4(RS)-metyl-l-oktynyl-magnesiumbromid og det resulterende produkt behandles med saltsyre i metanol for å bevirke spalting av tetrahydropyran-2-yl- og metoksymetoksy-gruppene hvilket således gir 3-hydr6ksy-2-(4(RS)-hydroksy-4(RS)-metyl-1-oktynyl)-5~oksocyklopent-l-enheptansyre. The tertiary alcohols used as defined in the preceding structural formula where R 1 is an alkyl radical, are preferably prepared by reacting the appropriate Grignard reagent with a 4-methoxymethoxycyclopentane derivative of the type described in US Patent No. 3-558,682. 2-Methoxy-4-methoxymethoxy-4-oxocyclopent-1-enheptanoic acid, for example, can thus be reacted with 4(RS)-tetrahydropyran-2-yloxy-4(RS)-methyl-1-octynyl-magnesium bromide and the resulting product is treated with hydrochloric acid in methanol to effect cleavage of the tetrahydropyran-2-yl and methoxymethoxy groups thus giving 3-hydroxy-2-(4(RS)-hydroxy-4(RS)-methyl-1-octynyl) -5~oxocyclopent-1-enheptanoic acid.

De optisk aktive R og S derivater oppnås ved å anvende, som utgangsmaterialer, de /passende optisk aktive acetyleniske alkoholer. 1-oktyn-4(RS)-ol, f.eks., omdannes til ftalsyre-halvester ved omsetning med ftalsyreanhydrid og halvesteren omsettes med (-) a-metylbenzylamin for å gi de diastereoisomere salter, som separeres ved fraksjonert krystallisering hvoretter hydrolyse foretas for å gi de enkelte R og S acetyleniske alkoholer. The optically active R and S derivatives are obtained by using, as starting materials, the appropriate optically active acetylenic alcohols. 1-octyn-4(RS)-ol, for example, is converted to the phthalic acid half-ester by reaction with phthalic anhydride and the half-ester is reacted with (-) α-methylbenzylamine to give the diastereoisomeric salts, which are separated by fractional crystallization followed by hydrolysis to give the individual R and S acetylenic alcohols.

Karboksylsyreestrene kan lett tilveiebringes ved forestring av de tilsvarende syrer. F.eks. kan 3_hydroksy-2-(4(RS)-hydroksy-1-oktynyl)-5-oksocyklppent-l-enheptansyre omsettes med eterisk diazometan for å gi metyl 3~hydroksy-2-(4(RS)-hydroksy-1-oktynyl)-5-oksocyklopent-l-enheptanoat. The carboxylic acid esters can be easily obtained by esterification of the corresponding acids. E.g. 3-hydroxy-2-(4(RS)-hydroxy-1-octynyl)-5-oxocyclpent-1-enheptanoic acid can be reacted with ethereal diazomethane to give methyl 3-hydroxy-2-(4(RS)-hydroxy-1-octynyl )-5-oxocyclopent-1-enheptanoate.

Alkanoylderivatene ifølge oppfinnelsen oppnås ved omsetning av de tilsvarende hydroksyforbindelser med et"alkansyre-anhydrid eller -halogenid, fortrinnsvis i nærvær av en egnet syre-akseptor slik som pyridin eller trietylamin. Således omsettes 3-hydroksy-2-(4(RS)-hydroksy-1-oktynyl)-5~oksocyklopent-1-enheptansyre med eddiksyreanhydrid og pyridin for oppnåelse av 3-acetoksy-2-(4(RS)-acetoksy-1-oktynyl)-5-oksocyklopent-l-enheptansyre. The alkanoyl derivatives according to the invention are obtained by reacting the corresponding hydroxy compounds with an alkanoic acid anhydride or halide, preferably in the presence of a suitable acid acceptor such as pyridine or triethylamine. Thus, 3-hydroxy-2-(4(RS)-hydroxy -1-octynyl)-5-oxocyclopent-1-enheptanoic acid with acetic anhydride and pyridine to obtain 3-acetoxy-2-(4(RS)-acetoxy-1-octynyl)-5-oxocyclopent-1-enheptanoic acid.

De utgangsforbindelser som anvendes i foreliggende oppfinnelse fremstilles hensiktsmessig ved anvendelse av oksoalkan-syrer og oksalsyreestere som utgangsstoffer. Som et spesielt eksempel kan 9~oksodekansyre kondenseres med dimetyloksalat i nærvær av kaliumtert-butoksyd for oppnåelse av 2,3,5~triokso-4-metoksalylcyklopentanheptansyre. Oppvarming av denne ester med saltsyre resulterer i tap av metoksyallyl-sidekjeden og man får således 2,3 >5-trioksocyklopentanheptansyre. Denne triketo-syre reduseres selektivt ved katalytisk ,-hydrogenering, hensiktsmessig med en 5% palladium-på-karbon-katalysator, til 2,5-diokso-3-hydroksycyklopentanheptansyre. Enoleter-dannelse med samtidig forestring av karboksylgruppen bevirkes f.eks. ved omsetning med en lavere alkanol i nærvær av en syrekatalysator. Reaksjonen av 2,5~diokso-3-hydroksycyklopentanheptansyre med metanol og svovelsyre i benzen gir således metyl 2-metoksy-4-hydroksy-5~oksocyklopent-l-enheptanoat. Omdannelse av den frie karboksyl- The starting compounds used in the present invention are suitably prepared by using oxoalkane acids and oxalic acid esters as starting substances. As a particular example, 9~oxodecanoic acid can be condensed with dimethyl oxalate in the presence of potassium tert-butoxide to obtain 2,3,5~trioxo-4-methoxyalylcyclopentaneheptanoic acid. Heating this ester with hydrochloric acid results in the loss of the methoxyallyl side chain and 2,3>5-trioxocyclopentaneheptanoic acid is thus obtained. This triketo acid is selectively reduced by catalytic ,-hydrogenation, suitably with a 5% palladium-on-carbon catalyst, to 2,5-dioxo-3-hydroxycyclopentaneheptanoic acid. Enol ether formation with simultaneous esterification of the carboxyl group is effected e.g. by reaction with a lower alkanol in the presence of an acid catalyst. The reaction of 2,5-dioxo-3-hydroxycyclopentaneheptanoic acid with methanol and sulfuric acid in benzene thus gives methyl 2-methoxy-4-hydroxy-5-oxocyclopent-1-eneheptanoate. Conversion of the free carboxyl

syre bevirkes hensiktsmessig ved forsåpning ved romtemperatur med fortynnet vandig natriumhydroksyd i metanol til 2-metoksy-4-hydroksy-5~oksocyklopent-l-enheptansyre. Kondensasjon av denne syre med 4(RS)-tetrahydropyran-2-yloksy-l-oktynylmagnesiumbromid eller litiumtetra(4(RS)-trietylsilyloksy-1-oktynyl)aluminat resulterer i 3"hydroksy-2-(4(RS)-tetrahydropyran-2-yloksy-l-oktynyl)-5-oksocyklopent-l-enheptansyre og 3-hydroksy-2-(4(RS)-trietylsilyloksy-1-oktynyl)-5~oksocyklopent-l-enheptansyre, respek-tivt. Fjerning av de beskyttende tetra-hydropyran-2-yl- og trietylsilylgrupper bevirkes ved syreavspaltning, hensiktsmessig med saltsyre i metanol, hvilket dermed gir 3-hydroksy-2-4(RS)-hydroksy-1-oktynyl)-5~oksocyklopent-1-enheptansyre. acid is conveniently effected by saponification at room temperature with dilute aqueous sodium hydroxide in methanol to 2-methoxy-4-hydroxy-5-oxocyclopent-1-enheptanoic acid. Condensation of this acid with 4(RS)-tetrahydropyran-2-yloxy-1-octynylmagnesium bromide or lithium tetra(4(RS)-triethylsilyloxy-1-octynyl)aluminate results in 3"hydroxy-2-(4(RS)-tetrahydropyran- 2-yloxy-1-octynyl)-5-oxocyclopent-1-enheptanoic acid and 3-hydroxy-2-(4(RS)-triethylsilyloxy-1-octynyl)-5-oxocyclopent-1-enheptanoic acid, respectively. Removal of the protective tetra-hydropyran-2-yl and triethylsilyl groups are effected by acid cleavage, suitably with hydrochloric acid in methanol, which thus gives 3-hydroxy-2-4(RS)-hydroxy-1-octynyl)-5~oxocyclopent-1-enheptanoic acid .

Forbindelsen ifølge oppfinnelsen utviser verdifulle farmakologiske egenskaper. De har f.eks. anti-ulcerogenisk og anti-sekretorisk virkning. I tillegg til dette har de anti-mikrobiell aktivitet hvilket vises ved deres evne til å inhibere den mikrobielle vekst av bakterier slik som Erwinia sp., protosoer slik som Tetrahymena pyriformis og fungi slik som Trichophyton ment.agrophytes og Verticillium albo-atrum. The compound according to the invention exhibits valuable pharmacological properties. They have e.g. anti-ulcerogenic and anti-secretory effect. In addition to this, they have anti-microbial activity which is shown by their ability to inhibit the microbial growth of bacteria such as Erwinia sp., protozoa such as Tetrahymena pyriformis and fungi such as Trichophyton ment.agrophytes and Verticillium albo-atrum.

Den anti-sekretoriske aktivitet til forbindelsen ifølge oppfinnelsen bestemmes ved hjelp av følgende prøvemetode: The anti-secretory activity of the compound according to the invention is determined by means of the following test method:

Voksne beaglehunder av hunkjønn med en vekt på 4,5_733Adult female beagle dogs with a weight of 4.5_733

kg utstyres med en gastrisk kanyle av teflon-rustfritt stål og implanteres i den mest avhengige del av maven nær antrum. Etter en restitueringsperiode på 1 måned etter det kirurgiske inngrep, gjennomgår dyrene en fase i omkring 20 timer og anbringes deretter i en lærrem som bare tillater begrenset bevegelse. Den gastriske kanylen åpnes og renses med varm (37°C) saltoppløsning. Hundene injiseres med en av to sekretogoger, histamin eller pentagastrin, kg is fitted with a Teflon-stainless steel gastric cannula and implanted in the most dependent part of the stomach near the antrum. After a recovery period of 1 month after the surgical intervention, the animals undergo a phase for about 20 hours and are then placed in a leather strap that allows only limited movement. The gastric cannula is opened and cleaned with warm (37°C) saline solution. The dogs are injected with one of two secretagogues, histamine or pentagastrin,

i en dose på omkring 2/3 av den som vil bevirke maksimal stimulering. in a dose of about 2/3 of that which will cause maximum stimulation.

Umiddelbart deretter blir forsøksforbindelsen oppløst i en iso-osmotisk bufferoppløsning administrert subkutant. Mavesaften oppsamles i løpet av 2 timer fulgt av administrasjon av den sekretogoge forbindelse og det totale volum måles. Disse resultater sammenlignes med de som oppnås fra kontrolldyr behandlet med den sekretogoge forbindelse alene. Forbindelsen bedømmes som aktiv hvis statistisk betydelig inhibering av sekretoriske parametere forekommer etter behandlingen. Immediately thereafter, the test compound is dissolved in an iso-osmotic buffer solution administered subcutaneously. The gastric juice is collected during 2 hours followed by administration of the secretagogue compound and the total volume is measured. These results are compared with those obtained from control animals treated with the secretagogue compound alone. The compound is judged to be active if statistically significant inhibition of secretory parameters occurs after treatment.

Forbindelsenes anti-ulcerogene egenskaper vises ved deres aktivitet i den prøve som er beskrevet i detalj i US-patent nr. 3.479•357• Prøvene som benyttes for å påvise den anti-bakterielle og anti-protosoiske aktivitet til forbindelsene ifølge oppfinnelsen er beskrevet i US-patent nr.3•692.799, mens metodene for påvisning av deres anti-fungale aktivitet" er angitt i US-patenf 3- 682. 951. The compounds' anti-ulcerogenic properties are shown by their activity in the test described in detail in US patent no. 3,479•357• The tests used to demonstrate the anti-bacterial and anti-protozoan activity of the compounds according to the invention are described in US -patent no. 3 • 692,799, while the methods for the detection of their anti-fungal activity" are indicated in US patent 3-682, 951.

Følgende eksempler illustrerer oppfinnelsen, og de angitte mengder av stoffer er gitt som vektdeler med mindre volumdeler er spesifisert. The following examples illustrate the invention, and the indicated amounts of substances are given as parts by weight unless parts by volume are specified.

Eksempel 1Example 1

Til en oppløsning av 56,5 deler kaliummetall i 936 deler tertiær-butylalkohol, ble det suksessivt tilsatt 105 deler dimetyloksalat og en oppløsning av 54 deler 9~oksodekansyre i 156 deler tertiær-butylalkohol. Denne tilsetning ble foretatt i løpet av et tidsrom.på omkring 40 minutter mens blandingen ble oppvarmet ved tilbakeløpstemperatur i en nitrogenatmosfære. Ved slutten av tilsetningsperioden ble oppvarming fortsatt i omkring 90 minutter og reaksjonsblandingen ble avkjølt og filtrert under nitrogen. Filterkaken ble tilsatt til en oppløsning av fortynnet saltsyre og denne blanding ble ekstrahert med kloroform. Kloro-formlaget ble separert, vasket med vann, tørket over vannfritt natriumsulfat og oppløsningsmidlet fjernet under redusert trykk. Omkrystalliserihg av den resulterende rest fra eter ga 2,3j5~triokso-4-metoksal'y.lcyklopentanheptansyre, smp. ca. 127-129°C. To a solution of 56.5 parts of potassium metal in 936 parts of tertiary butyl alcohol, 105 parts of dimethyl oxalate and a solution of 54 parts of 9-oxodecanoic acid in 156 parts of tertiary butyl alcohol were successively added. This addition was made over a period of about 40 minutes while the mixture was heated at reflux temperature in a nitrogen atmosphere. At the end of the addition period, heating was continued for about 90 minutes and the reaction mixture was cooled and filtered under nitrogen. The filter cake was added to a solution of dilute hydrochloric acid and this mixture was extracted with chloroform. The chloroform layer was separated, washed with water, dried over anhydrous sodium sulfate and the solvent removed under reduced pressure. Recrystallization of the resulting residue from ether gave 2,3-trioxo-4-methoxyal-1-cyclopentaneheptanoic acid, m.p. about. 127-129°C.

Eksempel 2Example 2

En blanding inneholdende 50 deler 2,3,5_triokso-4-metoksalylcyklopentanheptansyre og 2.880 volumdeler 2N saltsyre, ble langsomt destillert i en nitrogenatmosfære i omkring 2 timer, hvoretter det hele ble avkjølt og avfarget med aktivkull. Det således oppnåsse filtrat ble konsentrert til tørrhet under redusert trykk og den resulterende rest ble ekstrahert med etylacetat. Den organiske oppløsning ble vasket flere ganger med mettet vandig natriumklorid, deretter med vann og tilslutt tørket over vannfritt natriumsulfat og oppløsningsmidlet ble fjernet ved destillasjon under redusert trykk. Omkrystallisering av den resulterende rest fra vann ga ren 2,3,5-trioksocyklopentan-heptansyre, smp. ca. 102-104°C. A mixture containing 50 parts of 2,3,5_trioxo-4-methoxyalylcyclopentaneheptanoic acid and 2,880 parts by volume of 2N hydrochloric acid was slowly distilled in a nitrogen atmosphere for about 2 hours, after which the whole was cooled and decolorized with activated carbon. The filtrate thus obtained was concentrated to dryness under reduced pressure and the resulting residue was extracted with ethyl acetate. The organic solution was washed several times with saturated aqueous sodium chloride, then with water and finally dried over anhydrous sodium sulfate and the solvent was removed by distillation under reduced pressure. Recrystallization of the resulting residue from water gave pure 2,3,5-trioxocyclopentane-heptanoic acid, m.p. about. 102-104°C.

Eksempel 3Example 3

Til en oppløsning av 2 deler 2,3,5-trioksocyklopentan-heptansyre i 50 deler 70% vandig isopropylalkohol, ble det tilsatt 0,2 deler 5% palladium-på-karbon-katalysator og den resulterende reaksjonsblanding ble rystet med hydrogen ved atmosfæretrykk og romtemperatur inntil 1 molekylekvivalent hydrogen var absorbert-. Katalysatoren ble fjernet ved filtrering og oppløsningsmidlet ble destillert under redusert trykk og dette ga det urene produkt i form av en fast rest. Rensing ved omkrystallisering fra vann ga ren 2,5-diokso-3-hydroksycyklopentanheptansyre, smp. ca. 127-129,5°C. To a solution of 2 parts of 2,3,5-trioxocyclopentane-heptanoic acid in 50 parts of 70% aqueous isopropyl alcohol, 0.2 parts of 5% palladium-on-carbon catalyst was added and the resulting reaction mixture was shaken with hydrogen at atmospheric pressure and room temperature until 1 molecular equivalent of hydrogen had been absorbed-. The catalyst was removed by filtration and the solvent was distilled under reduced pressure to give the impure product as a solid residue. Purification by recrystallization from water gave pure 2,5-dioxo-3-hydroxycyclopentaneheptanoic acid, m.p. about. 127-129.5°C.

Eksempel 4Example 4

En oppløsning inneholdende 10 deler 2,5-diokso-3-hydroksycyklopentanheptansyre i 1000 volumdeler 1% metanolisk hydrogenklorid, ble lagret ved romtemperatur i ca. 60 timer, og ble deretter konsentrert til tørrhet under redusert trykk. Den resulterende rest ble oppløst i 280 deler metanol og 10 deler diazometan oppløst i eter ble tilsatt. Konsentrasjon av denne reaksjonsblanding til tørrhet ga en rest inneholdende metyl 2-metoksy-3-hydroksy-5-oksocyklopent-1-enheptanoat og metyl 2-metoksy-4-hydroksy-5~oksacyklopent-l-enheptanoat. Omkrystallisering fra eter ga den sistnevnte forbindelse. A solution containing 10 parts of 2,5-dioxo-3-hydroxycyclopentaneheptanoic acid in 1000 parts by volume of 1% methanolic hydrogen chloride was stored at room temperature for approx. 60 hours, and was then concentrated to dryness under reduced pressure. The resulting residue was dissolved in 280 parts of methanol and 10 parts of diazomethane dissolved in ether were added. Concentration of this reaction mixture to dryness gave a residue containing methyl 2-methoxy-3-hydroxy-5-oxocyclopent-1-eneheptanoate and methyl 2-methoxy-4-hydroxy-5-oxacyclopent-1-eneheptanoate. Recrystallization from ether gave the latter compound.

Det oppnådde materiale fra nevnte eterfiltrat ble oppløst i 42 deler etér og 4 deler metanol inneholdende 0,8 deler hydrogenklorid ble tilsatt. Den resulterende blanding ble hensatt ved romtemperatur i omkring 5 dager og det krystallinske materiale som ble utskilt var ytterligere metyl 2-metoksy-4-hydroksy-5-oksocyklopent-l-enhaptanoat. Filtratet ble konsentrert til tørrhet og resten omkrystallisert først fra aceton-heksan, deretter fra vann til oppnåelse av metyl 2,5--diokso-3-hydroksycyklopentanheptan-oatjsmp. ca. 98-90°C. The material obtained from said ether filtrate was dissolved in 42 parts of ether and 4 parts of methanol containing 0.8 parts of hydrogen chloride were added. The resulting mixture was left at room temperature for about 5 days and the crystalline material that separated was additional methyl 2-methoxy-4-hydroxy-5-oxocyclopent-1-enhaptanoate. The filtrate was concentrated to dryness and the residue recrystallized first from acetone-hexane, then from water to give methyl 2,5-dioxo-3-hydroxycyclopentaneheptane-oate m.p. about. 98-90°C.

Eksempel 5Example 5

Til en oppløsning av 5 deler metyl 2-metoksy-4-hydroksy-5-oksocyklopent-l-enheptanoat i 120 deler metanol, ble det tilsatt 185 deler 0,1N vandig natriumhydroksyd og den resulterende reaksjonsblanding ble holdt, ved romtemperatur i ca. 24 timer, og det organiske oppløsningsmiddel ble deretter fjernet ved destillasjon under redusert trykk. Den resterende blanding ble ekstrahert med benzen og det vandige lag ble separert, surgjort med fortynnet saltsyre og deretter ekstrahert med kloroform. Det resterende vandige lag ble separert og deretter ekstrahert med etylacetat. Den således oppnådde etylacetatoppløsning ble tørket over vannfritt natriumsulfat, deretter konsentrert til tørrhet og den resulterende rest ble renset ved omkrystallisering fra aceton hvilket ga 2-metoksy-4-hydroksy-5_oksocyklopent-l-enheptansyre, smp. ca. 113,5-117°C. To a solution of 5 parts of methyl 2-methoxy-4-hydroxy-5-oxocyclopent-1-eneheptanoate in 120 parts of methanol, 185 parts of 0.1N aqueous sodium hydroxide were added and the resulting reaction mixture was kept, at room temperature for about 24 hours, and the organic solvent was then removed by distillation under reduced pressure. The remaining mixture was extracted with benzene and the aqueous layer was separated, acidified with dilute hydrochloric acid and then extracted with chloroform. The remaining aqueous layer was separated and then extracted with ethyl acetate. The ethyl acetate solution thus obtained was dried over anhydrous sodium sulfate, then concentrated to dryness and the resulting residue was purified by recrystallization from acetone to give 2-methoxy-4-hydroxy-5-oxocyclopent-1-enheptanoic acid, m.p. about. 113.5-117°C.

Eksempel 6Example 6

Til en oppløsning av 2,5 deler 1-oktyn-4(RS)-ol i 10 deler benzen, ble det tilsatt 1,6 deler dihydropyran og 0,15 deler p-toluensulfonsyre. Den eksoterme reaksjon til å begynne med ble regulert ved avkjøling i et isbad og temperaturen ble således holdt ved ca. 25°C. Den resulterende reaksjonsblanding ble hensatt ved romtemperatur i omkring 5 timer, og ble deretter fortynnet med benzen, vasket suksessivt med fortynnet vandig natriumhydroksyd og vann, tørket over vannfritt natriumsulfat og deretter ble opp-løsningsmiddel fjernet under redusert trykk, hvilket ga 1-oktyn-4(RS)-ol 4-tetrahydropyran-2-yl eter. To a solution of 2.5 parts of 1-octyn-4(RS)-ol in 10 parts of benzene, 1.6 parts of dihydropyran and 0.15 parts of p-toluenesulfonic acid were added. The exothermic reaction was initially regulated by cooling in an ice bath and the temperature was thus kept at approx. 25°C. The resulting reaction mixture was left at room temperature for about 5 hours, and was then diluted with benzene, washed successively with dilute aqueous sodium hydroxide and water, dried over anhydrous sodium sulfate, and then the solvent was removed under reduced pressure to give 1-octyne-4 (RS)-ol 4-tetrahydropyran-2-yl ether.

Eksempel 7Example 7

Til en oppløsning av 12,6 deler 1-oktyn-4(RS)-ol 4-tetrahydropyran-2-yl eter i 112 deler tetrahydrofuran, ble det tilsatt 15,25 volumdeler 3,3 M eterisk etylmagnesiumbromid og den resulterende reaksjonsblanding ble hensatt ved romtemperatur i ca. 2 timer. Oppløsningen inneholdt 4(RS)-tetrahydropyran-2-yloksy-l-oktynylmagnesiumbromid. To a solution of 12.6 parts of 1-octyn-4(RS)-ol 4-tetrahydropyran-2-yl ether in 112 parts of tetrahydrofuran was added 15.25 parts by volume of 3.3 M ethereal ethylmagnesium bromide and the resulting reaction mixture was set aside at room temperature for approx. 2 hours. The solution contained 4(RS)-tetrahydropyran-2-yloxy-1-octynylmagnesium bromide.

Eksempel 8Example 8

Metode AMethod A

En oppløsning inneholdende 0,882 deler l-oktyn-4(RS)-A solution containing 0.882 parts of l-octyne-4(RS)-

ol 4-tetrahydropyran-2-yl eter i 20 volumdeler tetrahydrofuran,ol 4-tetrahydropyran-2-yl ether in 20 parts by volume of tetrahydrofuran,

ble avkjølt under nitrogen til omkring -5°C og 2 volumdeler 3N eterisk etylmagnesiumbromid ble tilsatt dråpevis under omrøring. Reaksjonsblandingen ble omrørt i omkteing 2,5 timer ved romtemperatur, og etter denne tid ble 0,256 deler 4-hydroksy-2-metoksy-5~oksocyklopent-l-enheptansyre oppløst i'30 volumdeler tetrahydrofuran tilsatt. Denne blanding ble oppvarmet ved tilbakeløpstemperatur under omrøring i omkring 16 timer, og ble deretter avkjølt og bråkjølt med fortynnet saltsyre. Omrøring ble fortsatt i ca. 10 minutter hvoretter tetrahydrofuranen ble fordampet og eter tilsatt. Eterlaget ble separert og ekstrahert med vandig kaliumkarbonat. was cooled under nitrogen to about -5°C and 2 parts by volume of 3N ethereal ethylmagnesium bromide was added dropwise with stirring. The reaction mixture was stirred in reverse for 2.5 hours at room temperature, and after this time 0.256 parts of 4-hydroxy-2-methoxy-5-oxocyclopent-1-enheptanoic acid dissolved in 30 parts by volume of tetrahydrofuran was added. This mixture was heated at reflux with stirring for about 16 hours, then cooled and quenched with dilute hydrochloric acid. Stirring was continued for approx. 10 minutes after which the tetrahydrofuran was evaporated and ether added. The ether layer was separated and extracted with aqueous potassium carbonate.

Det alkaliske ekstrakt ble deretter surgjort og ekstrahert med etylacetat. Etylacetatlaget ble separert, tørket over vannfritt natriumsulfat og -konsentrert til tørrhet under redusert trykk. The alkaline extract was then acidified and extracted with ethyl acetate. The ethyl acetate layer was separated, dried over anhydrous sodium sulfate and concentrated to dryness under reduced pressure.

Det resulterende urene produkt ble renset på en kromatografisk kolonne og dette ga 3~hydroksy-3~(4(RS)-hydroksy-1-oktynyl-5~oksocyklopent-l-enhept.ansyre, smp. ca. 77-80°C. The resulting crude product was purified on a chromatographic column to give 3-hydroxy-3-(4(RS)-hydroxy-1-octynyl-5-oxocyclopent-1-enheptanoic acid, mp ca. 77-80°C .

Metode BMethod B

Til en oppløsning av 3553deler l-oktyn-4(RS)-ol iTo a solution of 3553 parts of l-octyn-4(RS)-ol i

150 volumdeler tetrahydrofuran ved omkring 0°C, ble det dråpevis tilatt 16 volumdeler 3M eterisk etylmagnesiumbromid. Den resulterende reaksjonsblanding ble omrørt ved romtemperatur i omkring 5 timer hvoretter 1 del 4-hydroksy-2-metoksy-5-oksocyklopent-l-enheptansyre oppløst i 50 volumdeler tetrahydrofuran ble tilsatt dråpevis i 150 parts by volume of tetrahydrofuran at about 0°C, 16 parts by volume of 3M ethereal ethylmagnesium bromide were added dropwise. The resulting reaction mixture was stirred at room temperature for about 5 hours, after which 1 part of 4-hydroxy-2-methoxy-5-oxocyclopent-1-enheptanoic acid dissolved in 50 parts by volume of tetrahydrofuran was added dropwise in

løpet av ca. 30 minutter. Den resulterende reaksjonsblanding ble oppvarmet ved tilbakeløpstemperatur i ca. 5 timer og ble deretter avkjølt til omkring 0°C og 5 volumdeler 3M eterisk etylmagnesiumbromid ble tilsatt dråpevis. Blandingen ble omrørt i omkring 2 timer.ved ca. 0°C, deretter i ytterligere 2 timer ved romtemperatur og ble tilslutt oppvarmet ved tilbakeløpstemperatur i ca. 3 timer. Reaksjonsblandingen ble bråkjølt ved tilsetning av fortynnet saltsyre og oppløsningsmidlet ble fjernet ved destillasjon under redusert trykk. Den resulterende vandige blanding ble ekstrahert during approx. 30 minutes. The resulting reaction mixture was heated at reflux temperature for approx. 5 hours and was then cooled to about 0°C and 5 parts by volume of 3M ethereal ethylmagnesium bromide was added dropwise. The mixture was stirred for about 2 hours at approx. 0°C, then for a further 2 hours at room temperature and was finally heated at reflux temperature for approx. 3 hours. The reaction mixture was quenched by addition of dilute hydrochloric acid and the solvent was removed by distillation under reduced pressure. The resulting aqueous mixture was extracted

med etylacetat og dette organiske ekstrakt ble ekstrahert med with ethyl acetate and this organic extract was extracted with

fortynnet vandig kaliumkarbonat. Det alkaliske ekstrakt ble vasket med etylacetat, deretter surgjort med fortynnet saltsyre og ekstrahert med etylacetat. Det organiske lag ble tørket over vannfritt natriumsulfat og oppløsningsmidlet ble fjernet under redusert trykk for å oppnå det urene produkt, hvilket ble renset ved absorbsjon på en silisiumdioksydgel-kromatografisk kolonne og eluert med 10$ eter i benzen og dette ga 3~hydroksy-2-(4(RS)-hydroksy-l-oktynyl)-5~oksocyklopent-l-enheptansyre, smp. ca. 77-80°C. dilute aqueous potassium carbonate. The alkaline extract was washed with ethyl acetate, then acidified with dilute hydrochloric acid and extracted with ethyl acetate. The organic layer was dried over anhydrous sodium sulfate and the solvent was removed under reduced pressure to obtain the crude product, which was purified by absorption on a silica gel chromatographic column and eluted with 10% ether in benzene to give 3-hydroxy-2- (4(RS)-hydroxy-1-octynyl)-5-oxocyclopent-1-enheptanoic acid, m.p. about. 77-80°C.

Eksempel 9Example 9

Metode AMethod A

Til en omrørt oppløsning av 150 deler 4(RS)-metyl-l-oktyn-4(RS)-ol 4-tetrahydropyran-2-yl eter i ca. 1954 deler tørr tetrahydrofuran, ble det dråpevis tilsatt 283 volumdeler 3N To a stirred solution of 150 parts of 4(RS)-methyl-1-octyn-4(RS)-ol 4-tetrahydropyran-2-yl ether in approx. 1954 parts of dry tetrahydrofuran, 283 parts by volume of 3N were added dropwise

eterisk etylmagnesiumbromid mens temperaturen til oppløsningen ble holdt under 30°C. Omrøring ble fortsatt i ca. 1,5 timer hvoretter 31,5 deler 2-metoksy-4-metoksymetoksy-4-oksocyklopent-l-enhe.ptansyre oppløst i ca. 710 deler tetrahydrofuran ble tilsatt i løpet av ca. 10 minutter. Reaksjonsblandingen ble hensatt i ca. 16 timer hvoretter den ble bråkjølt ved tilsetning av fortynnet saltsyre. Oppløsningsmidlet ble fjernet ved destillasjon under redusert' trykk og resten ble fortynnet med benzen. Det organiske lag ble separert og vasket med vann og deretter destillert til tørrhet til 5"(4(RS)-mety1-4(RS)-tetrahydropyran-2-yloksy-1-oktynyl)-4-metylsyrnetoksy-2-metoksycyklopent-l-enheptansyre. ethereal ethylmagnesium bromide while the temperature of the solution was kept below 30°C. Stirring was continued for approx. 1.5 hours, after which 31.5 parts of 2-methoxy-4-methoxymethoxy-4-oxocyclopent-1-enheptanoic acid dissolved in approx. 710 parts of tetrahydrofuran were added during approx. 10 minutes. The reaction mixture was set aside for approx. 16 hours after which it was quenched by adding dilute hydrochloric acid. The solvent was removed by distillation under reduced pressure and the residue was diluted with benzene. The organic layer was separated and washed with water and then distilled to dryness to 5"(4(RS)-methyl-4(RS)-tetrahydropyran-2-yloxy-1-octynyl)-4-methylacid-ethoxy-2-methoxycyclopent-1 -enheptanoic acid.

Det sistnevnte produkt ble oppløst i 4400 deler aceton, l600 deler vann og 71 deler konsentrert saltsyre og den resulterende blanding ble oppvarmet ved tilbakeløpstemperatur i omkring 20 timer. Fjerning av aceton under redusert trykk ga en vandig oppløsning The latter product was dissolved in 4400 parts of acetone, 1600 parts of water and 71 parts of concentrated hydrochloric acid and the resulting mixture was heated at reflux temperature for about 20 hours. Removal of acetone under reduced pressure gave an aqueous solution

som ble ekstrahert med l:.l benzen-eter. Benzen-eteroppløsningen ble ekstrahert med <5% vandig kaliumkarbonat og dette ekstrakt ble sur-gj ort med saltsyre og deretter ekstrahert med benzen-eter. Sistnevnte ekstrakt ble tørket over vannfritt natriumsulfat og opp-løsningsmidlet ble fjernet ved destillasjon under redusert trykk til en oljeaktig rest, som ble renset ved kromatografi på en kisel-syrekolonne. Det urene produkt ble ytterligere renset ved omkrystallisering fra eter, hvilket ga 3~hydr.oksy-2-( 4(RS)-metyl- which was extracted with 1:.1 benzene ether. The benzene ether solution was extracted with <5% aqueous potassium carbonate and this extract was acidified with hydrochloric acid and then extracted with benzene ether. The latter extract was dried over anhydrous sodium sulfate and the solvent was removed by distillation under reduced pressure to an oily residue, which was purified by chromatography on a silicic acid column. The crude product was further purified by recrystallization from ether, which gave 3-hydroxy-2-(4(RS)-methyl-

4(RS)-hydroksy-1-oktynyl)-5-oksocyklopent-l-enheptansyre, som er kjennetegnet ved IR-absorbsjonsmaksimum ved ca. 1715 cm ^ og UV-absorbsjonsmaksima ved ca. 270 nm (e23000). 4(RS)-hydroxy-1-octynyl)-5-oxocyclopent-1-enheptanoic acid, which is characterized by the IR absorption maximum at approx. 1715 cm ^ and UV absorption maxima at approx. 270 nm (e23000).

Metode BMethod B

Blandingen inneholdende 2,4 deler 4(RS)-mety1-loktyn-4-(RS)-ol, 3,3 deler trietylsilylklorid, 10 volumdeler N,N-dimetyl-formamid og 3 deler trietylamin, ble tilbakeløpskokt under omrøring natten over hvoretter 1 del trietylsilylklorid ble tilsatt og tilbakeløpskoking fortsatt i ca. 2 timer. Reaksjonsblandingen ble deretter avkjølt til romtemperatur og helt i blandingen bestående av eter og vann. Det organiske lag ble separert og vasket med IN saltsyre og deretter vasket med vann. Fjerning av oppløsnings-midlet ved destillasjon under redusert trykk ga 4(RS)-metyl-oktyn-4(RS)-ol trietylsilyleter. The mixture containing 2.4 parts of 4(RS)-methyl-loctyn-4-(RS)-ol, 3.3 parts of triethylsilyl chloride, 10 parts by volume of N,N-dimethylformamide and 3 parts of triethylamine was refluxed with stirring overnight, after which 1 part triethylsilyl chloride was added and reflux continued for approx. 2 hours. The reaction mixture was then cooled to room temperature and poured into the mixture consisting of ether and water. The organic layer was separated and washed with 1N hydrochloric acid and then washed with water. Removal of the solvent by distillation under reduced pressure gave 4(RS)-methyl-octyn-4(RS)-ol triethylsilyl ether.

En oppløsning bestående av 2 deler 4(RS>-metyl-l-oktyn-4(RS)-ol trietylsilyleter i 25 deler tetrahydrofuran, ble avkjølt til ca. -40°C med et tørt isbad og 353volumdeler 2,42 molar butyllitium i heksan ble tilsatt og den resulterende blanding ble hensatt til romtemperatur var oppnådd og deretter ble blandingen omrørt i ca. 30 minutter. Blandingen ble deretter avkjølt til -40°C i et tørt isbad og 0,268 deler aluminiumklorid ble tilsatt. Denne blanding ble hensatt til romtemperatur var oppnådd og 0,48 deler metyl 2-metoksy-4-hydroksy-5_oksocyklopent-l-enheptanoat oppløst i tetrahydrofuran ble tilsatt. Blandingen ble omrørt ved romtemperatur i ca. 2 timer hvoretter blandingen ble fortynnet med eter og surgjort med fortynnet saltsyre. Oppløsningsmidlet ble fjernet ved fordampning ved romtemperatur og resten ble oppløst i en blanding av metanol og fortynnet saltsyre. Denne blanding ble holdt ved romtemperatur i ca. 2 timer og ble deretter behandlet med fortynnet vandig kaliumkarbonat og hensatt ved romtemperatur natten over. Det alkaliske ekstrakt ble vas:ket med etylacetat, deretter surgjort med saltsyre og ekstrahert med etylacetat. A solution consisting of 2 parts of 4(RS>-methyl-1-octyn-4(RS)-ol triethylsilyl ether in 25 parts of tetrahydrofuran was cooled to about -40°C with a dry ice bath and 353 parts by volume of 2.42 molar butyllithium in hexane was added and the resulting mixture was allowed to reach room temperature and then the mixture was stirred for about 30 minutes. The mixture was then cooled to -40°C in a dry ice bath and 0.268 parts of aluminum chloride was added. This mixture was allowed to reach room temperature. was obtained and 0.48 parts of methyl 2-methoxy-4-hydroxy-5-oxocyclopent-1-eneheptanoate dissolved in tetrahydrofuran was added. The mixture was stirred at room temperature for about 2 hours after which the mixture was diluted with ether and acidified with dilute hydrochloric acid. The solvent was removed by evaporation at room temperature and the residue was dissolved in a mixture of methanol and dilute hydrochloric acid.This mixture was kept at room temperature for about 2 hours and then treated with dilute aqueous potassium carbonate and set at room temperature overnight. The alkaline extract was washed with ethyl acetate, then acidified with hydrochloric acid and extracted with ethyl acetate.

Det organiske lag ble tørket over vannfritt natriumsulfat og oppløsningsmidlet ble fjernet ved destillasjon under redusert trykk til en viskøs gul olje. Dette resulterende urene produkt ble renset på en kromatografisk kolonne hvilket ga 3-hydroksy-2-(4(RS)-metyl-4(RS)-hydroksy-l-oktynyl)-5-oksocyklopent-l-enheptan syre, som er kjennetegnet ved IR-maksimum ved ca. 1715 cm 1 og UV-absorbsjonsmaksima ved ca. 270 nm (e23000). The organic layer was dried over anhydrous sodium sulfate and the solvent was removed by distillation under reduced pressure to a viscous yellow oil. This resulting crude product was purified on a chromatographic column to give 3-hydroxy-2-(4(RS)-methyl-4(RS)-hydroxy-1-octynyl)-5-oxocyclopent-1-enheptanoic acid, which is characterized at the IR maximum at approx. 1715 cm 1 and UV absorption maxima at approx. 270 nm (e23000).

Eksempel 10vExample 10v

Til en blanding bestående av 7 deler kaliumhydroksyd oppløst i 13 deler vann og 100 volumdeler eter, ble det tilsatt 6 deler N-nitroso-metylurea. Den resulterende blanding ble omrørt inntil mesteparten av det faste stoffet var oppløst og den gule eteriske oppløsning ble dekantert i en oppløsning bestående av 1 del 3-hydroksy-2-(4(RS)-hydroksy-1-oktynyl)-5~oksocyklopent-1-enheptansyre oppløst i 50 volumdeler kald eter. Reaksjonsblandingen ble deretter hensatt ved sin temperatur i noen minutter hvoretter overskudd reagent ble ødelagt ved dråpevis tilsetning av iseddik. Når eteroppløsningen ble fargeløs, ble den vasket suksessivt med kaldt vann, kald fortynnet vandig natriumbikarbonat og kaldt vann, og deretter tørket over vannfritt natriumsulfat og konsentrert til tørrhet under redusert trykk. Det således oppnådde produkt ble videre renset ved absorbsjon på en kiselsyre-kromatografisk kolonne fulgt av eluering med etylacetat-benzenblandinger, hvilket ga metyl 3-hydroksy-2-(4(RS)-hydroksy-1-oktynyl)-5-oksocyklopent-l-enheptanoat. To a mixture consisting of 7 parts of potassium hydroxide dissolved in 13 parts of water and 100 parts by volume of ether, 6 parts of N-nitroso-methylurea were added. The resulting mixture was stirred until most of the solid had dissolved and the yellow ethereal solution was decanted into a solution consisting of 1 part of 3-hydroxy-2-(4(RS)-hydroxy-1-octynyl)-5~oxocyclopent- 1-enheptanoic acid dissolved in 50 parts by volume of cold ether. The reaction mixture was then allowed to stand at its temperature for a few minutes, after which excess reagent was destroyed by the dropwise addition of glacial acetic acid. When the ether solution became colorless, it was washed successively with cold water, cold dilute aqueous sodium bicarbonate and cold water, and then dried over anhydrous sodium sulfate and concentrated to dryness under reduced pressure. The product thus obtained was further purified by absorption on a silica chromatographic column followed by elution with ethyl acetate-benzene mixtures, which gave methyl 3-hydroxy-2-(4(RS)-hydroxy-1-octynyl)-5-oxocyclopent-1 -enheptanoate.

Eksempel 11 ■ Example 11 ■

En blanding bestående av 25 deler 3-hydroksy-2-(4(RS)-hydroksy-l-oktynyl)-5~oksocyklopent-l-enheptansyre, 10 deler eddiksyreanhydrid og 10 deler pyridin, ble hensatt ved romtemperatur i ca. 16 timer og ble deretter helt forsiktig i et overskudd av kald vandig sitronsyre. Den resulterende vandige blanding ble hensatt ved romtemperatur i ca. 1 time og ble deretter ekstrahert flere ganger med eter. De kombinerte eterekstrakter ble vasket med kaldt vann, tørket over vannfritt natriumsulfat og konsentrert under redusert trykk. Den resulterende rest ble renset ved absorbsjon på en kiselsyre-kromatografisk kolonne fulgt av eluering med benzen-etylacetatblandinger, hvilket ga 3-acetoksy-2-(4(RS)-acetoksy-1-oktynyl)-5-oksocyklopent-l-anheptansyre. A mixture consisting of 25 parts of 3-hydroxy-2-(4(RS)-hydroxy-1-octynyl)-5~oxocyclopent-1-enheptanoic acid, 10 parts of acetic anhydride and 10 parts of pyridine was left at room temperature for approx. 16 hours and was then thoroughly immersed in an excess of cold aqueous citric acid. The resulting aqueous mixture was left at room temperature for approx. 1 hour and was then extracted several times with ether. The combined ether extracts were washed with cold water, dried over anhydrous sodium sulfate and concentrated under reduced pressure. The resulting residue was purified by absorption on a silica chromatographic column followed by elution with benzene-ethyl acetate mixtures to give 3-acetoxy-2-(4(RS)-acetoxy-1-octynyl)-5-oxocyclopent-1-anheptanoic acid.

Eksempel 12Example 12

En blanding bestående av 6,3 deler l-oktyn-4-(RS)-ol, 7,4 dier ftalsyreanhydrid og 10 deler pyridin, ble oppvarmet ved tilbakeløpstemperatur i ca. 3 timer, deretter ble den avkjølt til romtemperatur, fortynnet med eter og vasket med fortynnet saltsyre. Ekstraksjon med fortynnet vandig natriumhydroksyd fulgt av sur-gjøring av det alkaliske ekstrakt og ekstraksjon av den surgjorte blanding med eter ga en organisk oppløsning, som ble tørket over vannfritt natriumsulfat, avfarget med aktivkull og deretter ble oppløsningsmidlet fjernet hvilket ga l-oktyn-4(RS)-ol ftalat. A mixture consisting of 6.3 parts of 1-octyn-4-(RS)-ol, 7.4 parts of di-phthalic anhydride and 10 parts of pyridine was heated at reflux temperature for approx. 3 hours, then it was cooled to room temperature, diluted with ether and washed with dilute hydrochloric acid. Extraction with dilute aqueous sodium hydroxide followed by acidification of the alkaline extract and extraction of the acidified mixture with ether gave an organic solution, which was dried over anhydrous sodium sulfate, decolorized with activated charcoal and then the solvent was removed to give l-octyne-4( RS)-ol phthalate.

En blanding inneholdende 2,24 deler av sistnevnte ester, 0,99 deler L(-) a-metylbenzylamin og 125 volumdeler diklormetan, ble omrørt i ca. 10 minutter, deretter ble oppløsningsmidlet fjernet under redusert trykk og fortynnet med eter. Produktet ble renset ved omkrystallisering fra cykloheksan hvilket ga 1-oktyn-4(S)-ol ftalat IL(-) a-mety lbenzylaminsaltet, smp. ca. 109-112°C. A mixture containing 2.24 parts of the latter ester, 0.99 parts of L(-) α-methylbenzylamine and 125 parts by volume of dichloromethane was stirred for approx. 10 minutes, then the solvent was removed under reduced pressure and diluted with ether. The product was purified by recrystallization from cyclohexane which gave 1-octyn-4(S)-ol phthalate IL(-) α-methylbenzylamine salt, m.p. about. 109-112°C.

En blanding omfattende 1,07 deler av sistnevnte salt,A mixture comprising 1.07 parts of the latter salt,

10 volumdeler IN natriumhydroksyd og 10 volumdeler metanol, ble oppvarmet ved ca. 60°C i omkring 90 minutter, og ble deretter av-kjølt og fortynnet med heksan. Heksanlaget ble separert, vasket med vann", tørket over vannfritt natriumsulf at og oppløsningsmidlet ble fjernet under redusert trykk og dette ga 1-oktyn-4(S)-ol, som er kjennetegnet ved en optisk rotasjon i eter på -46,5°• 10 parts by volume IN sodium hydroxide and 10 parts by volume methanol were heated at approx. 60°C for about 90 minutes, and was then cooled and diluted with hexane. The hexane layer was separated, washed with water", dried over anhydrous sodium sulfate and the solvent was removed under reduced pressure to give 1-octyn-4(S)-ol, which is characterized by an optical rotation in ether of -46.5° •

Eksempel 13Example 13

Ved gjentagelse av metoden i eksempel 12 under anvendelse av D(+) a-metylbenzylamin istedenfor L(-) a-metylbenzylamin ble 1-oktyn-4(R)-ol oppnådd. By repeating the method in example 12 using D(+) α-methylbenzylamine instead of L(-) α-methylbenzylamine, 1-octyn-4(R)-ol was obtained.

Eksempel 14Example 14

Når en ekvivalent mengde av enten l-oktyn-4-(R)-ol 4-tetrahydropyran-2-yl .eter eller l-oktyn-4(S)-ol-4-tetrahydro-pyran-2-yl eter ble benyttet i metoden i eksempel 8, metode A, When an equivalent amount of either 1-octyn-4-(R)-ol 4-tetrahydropyran-2-yl ether or 1-octyn-4(S)-ol-4-tetrahydro-pyran-2-yl ether was used in the method of example 8, method A,

ble 3~hydroksy-2-(4(R)-hydroksy-l-oktynyl)-5-oksocyklopent-l-enhaptansyre og 3~hydroksy-2-(4(S)-hydroksy-1-oktynyl)-5-oksocyklopent-1-enheptansyre. became 3-hydroxy-2-(4(R)-hydroxy-1-octynyl)-5-oxocyclopent-1-enhaptanoic acid and 3-hydroxy-2-(4(S)-hydroxy-1-octynyl)-5-oxocyclopent -1-enheptanoic acid.

Eksempel 15Example 15

Når en ekvivalent mengde av enten 1-oktyn-4(R)-o1When an equivalent amount of either 1-octyne-4(R)-o1

eller l-oktyn-4(S)-ol ble benyttet i eksempel 8, metode B, ble det oppnådd 3_hydroksy-2-(4(R)-hydroksy-1-oktynyl)-5-oksocyklopent-l-enheptansyre og 3-hydroksy-2-(4(S)-hydroksy-l-oktynyl)-5- or 1-octyn-4(S)-ol was used in example 8, method B, 3-hydroxy-2-(4(R)-hydroxy-1-octynyl)-5-oxocyclopent-1-enheptanoic acid and 3- hydroxy-2-(4(S)-hydroxy-1-octynyl)-5-

oksocyklopent-1-enheptansyre. oxocyclopent-1-enheptanoic acid.

Claims (7)

1. Fremgangsmåte til fremstilling av en forbindelse med den1. Method of making a compound therewith generelle formel:general formula: hvor R er hydrogen eller et alkylradikal med 1-7 karbonatomer; R^ er hydrogen eller et alkanoylradikal med 1-7 karbonatomer; R2 er hydrogen eller et alkanoylradikal med 1-7 karbonatomer; R2 er hydrogen eller et alkylradikal med 1-7 karbonatomer; m er 6 eller 7, og hvor de bølgeformede linjer indikerer den alternative R og S absolutte stereokjemiske konfigurasjon eller den epimere blanding, karakterisert ved at en forbindelse med den generelle formel where R is hydrogen or an alkyl radical of 1-7 carbon atoms; R 1 is hydrogen or an alkanoyl radical with 1-7 carbon atoms; R 2 is hydrogen or an alkanoyl radical of 1-7 carbon atoms; R 2 is hydrogen or an alkyl radical of 1-7 carbon atoms; m is 6 or 7, and where the wavy lines indicate the alternative R and S absolute stereochemical configuration or the epimeric mixture, characterized in that a compound with the general formula hvior R er hydrogen eller et alkylradikal med 1-7 karbonatomer;R' er hydrogen eller metoksymetyl; alkylgruppen inneholder 1-4 karbonatomer; m er 6 eller 7; og den bølgeformede linje indikerer den alternative R og S absolutte stereokjemiske konfigurasjon eller den epimere blanding, kondenseres med en organometallisk forbindelse med den generelle formel: where R is hydrogen or an alkyl radical with 1-7 carbon atoms; R' is hydrogen or methoxymethyl; the alkyl group contains 1-4 carbon atoms; m is 6 or 7; and the wavy line indicates the alternative R and S absolute stereochemical configuration or the epimeric mixture, condensed with an organometallic compound of the general formula: hvor R-j er hydrogen eller et alkylradikal med 1-7 karbonatomer; R" er hydrogen, tetrahydrppyran-2-yl, eller trialkylsily1, hvor alkylgruppen inneholder 1-4 karbonatomer; og de bølgeformede linjer indikerer den alternative R og S absolutte stereokjemiske konfigurasjon eller den epimere blanding; forutsatt at R bare er hydrogen når Grignard-reagensen anvendes; eventuelt fulgt av forestring. where R-j is hydrogen or an alkyl radical with 1-7 carbon atoms; R" is hydrogen, tetrahydropyran-2-yl, or trialkylsily1, where the alkyl group contains 1-4 carbon atoms; and the wavy lines indicate the alternative R and S absolute stereochemical configuration or the epimeric mixture; provided that R is only hydrogen when the Grignard reagent is used; optionally followed by esterification. 2. Fremgangsmåte ifølge krav 1, karakterisert _ ved at R er hydrogen; R" er hydrogen, tetrahydropyran-2-yl eller trialkylsilyl, hvor alkylgruppen inneholder 1-4 karbonatomer, og m er 6. 2. Method according to claim 1, characterized in that R is hydrogen; R" is hydrogen, tetrahydropyran-2-yl or trialkylsilyl, where the alkyl group contains 1-4 carbon atoms, and m is 6. 3. Fremgangsmåte ifølge krav 1, til fremstilling av 2-(4(RS)-hydroksy-1-oktynyl)-3-hydroksy-5-oksocyklopent-1-enheptansyre, karakterisert ved at 4-hydroksy-2-metoksy-5~ oksocyklopent-1-enheptansyre omsettes med et organometallisk derivat av l-oktyn-4(RS)-ol. 3. Method according to claim 1, for the preparation of 2-(4(RS)-hydroxy-1-octynyl)-3-hydroxy-5-oxocyclopent-1-enheptanoic acid, characterized in that 4-hydroxy-2-methoxy-5~ oxocyclopent-1-enheptanoic acid is reacted with an organometallic derivative of l-octyn-4(RS)-ol. 4. Fremgangsmåte ifølge krav 1 til fremstilling av 2-(4(R)-hydroksy-1-oktynyl)~3 -hydroksy-5-oksocyklopent-1-enheptansyre, karakterisert ved at 4-hydroksy-2-metoksy-5~ oksocyklopent-l-enheptansyre omsettes med et organometallisk derivat av l-oktyn-4(R)-ol. 4. Process according to claim 1 for the production of 2-(4(R)-hydroxy-1-octynyl)~3-hydroxy-5-oxocyclopent-1-enheptanoic acid, characterized in that 4-hydroxy-2-methoxy-5~ oxocyclopent -1-enheptanoic acid is reacted with an organometallic derivative of l-octyn-4(R)-ol. 5. Fremgangsmåte ifølge krav 1, til fremstilling av 2-(4(S)-hydroksy-1-oktynyl)-3-hydroksy-5-oksocyklopent-1-enheptansyre, karakterisert ved at 4-hydroksy-2-metoksy-5~ oksocyklopent-.l-enheptansyre omsettes med et organometallisk derivat av i-oktyn-4(S)-l. 5. Process according to claim 1, for the preparation of 2-(4(S)-hydroxy-1-octynyl)-3-hydroxy-5-oxocyclopent-1-enheptanoic acid, characterized in that 4-hydroxy-2-methoxy-5~ oxocyclopent-.1-enheptanoic acid is reacted with an organometallic derivative of i-octyne-4(S)-1. 6. Fremgangsmåte ifølge krav 1, til fremstilling av metyl 2- ( 4 (RS )-hydroksy- 1-oktynyl) -'3r\hydroksy- 5-oksocyklopent-1-enheptanoa-t, karakterisert ved at 4-hydroksy-2-metoksy-5-oksocyklopent-l-enheptansyre omsettes med et organometallisk derivat av l-oktyn-4(RS)-ol fulgt av hydrolyse og etterfølgende metylering. 6. Process according to claim 1, for the preparation of methyl 2-(4 (RS)-hydroxy-1-octynyl)-3r\hydroxy-5-oxocyclopent-1-enheptanoa-t, characterized in that 4-hydroxy-2- methoxy-5-oxocyclopent-1-enheptanoic acid is reacted with an organometallic derivative of l-octyn-4(RS)-ol followed by hydrolysis and subsequent methylation. 7. Fremgangsmåte ifølge krav 1, til fremstilling av 2-(4(RS)-acetoksy-1-oktynyl)-3-acetoksy-5-oksocyklopent-1-enheptansyre, karakterisert ved at 4-hydroksy-2-metoksy-5-oksocyklopent-l-enheptansyre omsettes med et organometallisk derivat av l-oktyn-4-(RS)-ol, fulgt av hydrolyse og etterfølgende acetylering. 8.. Fremgangsmåte ifølge krav 1, til fremstilling av 2-(4(RS)-hydr oksy-4 (RS')-metyl-1-oktynyl )-3-hydr oksy-5-oksocyklopent-1-enheptansyre, karakterisert ved at 4-hydroksy-2-metoksy-5-oksocyklopent-l-enheptansyre omsettes med et organometallisk derivat av 4(RS)-metyl-l-oktyn-4(RS)-ol.7. Process according to claim 1, for the preparation of 2-(4(RS)-acetoxy-1-octynyl)-3-acetoxy-5-oxocyclopent-1-enheptanoic acid, characterized in that 4-hydroxy-2-methoxy-5- oxocyclopent-1-enheptanoic acid is reacted with an organometallic derivative of l-octyn-4-(RS)-ol, followed by hydrolysis and subsequent acetylation. 8.. Process according to claim 1, for the production of 2-(4(RS)-hydroxy-4 (RS')-methyl-1-octynyl)-3-hydroxy-5-oxocyclopent-1-enheptanoic acid, characterized by that 4-hydroxy-2-methoxy-5-oxocyclopent-1-enheptanoic acid is reacted with an organometallic derivative of 4(RS)-methyl-1-octyn-4(RS)-ol.
NO743960A 1973-11-02 1974-11-04 NO743960L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US412428A US3868413A (en) 1970-06-04 1973-11-02 2-(4-Hydroxy-1-alkynyl)-5-oxocyclopent-1-enealkanoic acids, 3-hydroxy congeners corresponding and derivatives thereof

Publications (1)

Publication Number Publication Date
NO743960L true NO743960L (en) 1975-05-26

Family

ID=23632935

Family Applications (1)

Application Number Title Priority Date Filing Date
NO743960A NO743960L (en) 1973-11-02 1974-11-04

Country Status (13)

Country Link
JP (1) JPS50111048A (en)
AT (1) AT336813B (en)
AU (1) AU7490774A (en)
BE (1) BE821817A (en)
CA (1) CA1042882A (en)
DE (1) DE2451798A1 (en)
ES (1) ES431553A1 (en)
FR (1) FR2249660B1 (en)
GB (1) GB1458245A (en)
NL (1) NL7414345A (en)
NO (1) NO743960L (en)
SE (1) SE7413813L (en)
ZA (1) ZA747066B (en)

Also Published As

Publication number Publication date
SE7413813L (en) 1975-05-05
FR2249660A1 (en) 1975-05-30
ZA747066B (en) 1975-12-31
JPS50111048A (en) 1975-09-01
BE821817A (en) 1975-05-05
AU7490774A (en) 1976-05-06
FR2249660B1 (en) 1977-09-09
AT336813B (en) 1977-05-25
ES431553A1 (en) 1976-11-01
NL7414345A (en) 1975-05-07
DE2451798A1 (en) 1975-05-07
GB1458245A (en) 1976-12-08
ATA875974A (en) 1976-09-15
CA1042882A (en) 1978-11-21

Similar Documents

Publication Publication Date Title
US2359096A (en) beta-substituted-delta alpha, beta-gamma-butyrolactones and beta-substituted - beta - hydroxy-gamma-butyrolactones and methods of preparing them
NO800796L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY EFFECTIVE CHROMONDERIVATIVES
NO140977B (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 2-AMINO-1,4-DIHYDROPYRIDINES
IL30735A (en) Process for preparing tetra and hexa hydroindane derivatives
US4673761A (en) Process for preparing anti-inflammatory cycloalkylidenemethylphenylacetic acid derivatives
NO140978B (en) ANALOGICAL PROCEDURE FOR PREPARATION OF THERAPEUTICALLY ACTIVE ISOKINOLINE DERIVATIVES
US3524867A (en) Process for producing cyclopenta (b)pyrans
NO750819L (en)
Sheehan et al. The synthesis of substituted penicillins and simpler structural analogs. VIII. Phthalimidomalonaldehydic esters: Synthesis and condensation with penicillamine
NO743960L (en)
Salo et al. N-Acylenamines from oxazolines. New route to 2-acetamidogylcals
US3868413A (en) 2-(4-Hydroxy-1-alkynyl)-5-oxocyclopent-1-enealkanoic acids, 3-hydroxy congeners corresponding and derivatives thereof
JPH10265441A5 (en)
Strunz et al. Fittig bislactones in cyclopentenone synthesis: short synthesis of methylenomycin B
NO175780B (en) Analogous Process for the Preparation of Therapeutically Active Substituted Dibenzofurans
NO750264L (en)
US3836581A (en) 1-alkoximino-2-(omega-substituted-alkyl)-2-cyclopentenes
Sudo et al. Synthesis of carolic acid
US4087621A (en) 7-{3-Hydroxy-2β-[4-hydroxy-4-(lower alkyl)-trans-1-octen-1-yl]-5-oxocyclopent-1α-yl}hept-5-cis-enoic acids and related compounds
US2842559A (en) Synthesis of estrone intermediates
US4201870A (en) Process for the preparation of 2-(3-benzoylphenyl)-propionic acid
US3932496A (en) Mono- and dialkylated prostynoic acid derivatives
US2759013A (en) Steroid intermediates
US4162364A (en) Process for the preparation of 2-(3-benzoylphenyl)-propionic acid
US4172953A (en) 2,3,5-Trisubstituted cyclopentanealkenoic acids, derivatives thereof and intermediates thereto